United States · FDA National Drug Code directory

Embriva

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 85477-322_3c362de4-1eda-83be-e063-6394a90a10fc
Product NDC: 85477-322
Form: TABLET
Composition / generic term: ASCORBIC ACID, CHOLECALCIFEROL, THIAMINE, PYRIDOXAL PHOSPHATE, FOLIC ACID, METHYLCOBALAMIN, CALCIUM CARBONATE, FERROUS GLUCONATE, POTASSIUM IODIDE
Labeler: Oncora Pharma, LLC
Marketing category: UNAPPROVED DRUG OTHER
Marketing start / end (source format): 20250808
Source listing expiry: 20261231

Source-listed ingredients

PYRIDOXAL PHOSPHATE ANHYDROUS — 2.5 mg/1
POTASSIUM IODIDE — .15 mg/1
ASCORBIC ACID — 125 mg/1
CHOLECALCIFEROL — .0125 mg/1
THIAMINE — 1.4 mg/1
FOLIC ACID — 1 mg/1
METHYLCOBALAMIN — 1 mg/1
CALCIUM CARBONATE — 200 mg/1
FERROUS GLUCONATE — 13 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

30 TABLET in 1 BOTTLE, PLASTIC (85477-322-30) · 85477-322-30

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →